Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and physalin b

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with physalin b in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(physalin b)
Trials
(physalin b)
Recent Studies (post-2010) (physalin b)
9,15618755242024

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Azambuja, P; Castro, DP; Figueiredo, MB; Garcia, ES; Genta, FA; Ribeiro, IM; Tomassini, TC1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and physalin b

ArticleYear
Physalin B inhibits Rhodnius prolixus hemocyte phagocytosis and microaggregation by the activation of endogenous PAF-acetyl hydrolase activities.
    Journal of insect physiology, 2009, Volume: 55, Issue:6

    Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Arachidonic Acid; Cell Aggregation; Enzyme Activation; Hemocytes; Insect Proteins; Phagocytosis; Platelet Activating Factor; Rhodnius; Saccharomyces cerevisiae; Secosteroids

2009